Írország - angol - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - trimethoprim; sulphadiazine - intramammary suspension - 40, 200 mg/syringe - sulfonamides and trimethoprim for intramammary use

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 33665 - posterior-stabilized total knee prosthesis - the columbus rev f mc gliding surface is a fixed bearing, medium constraint meniscal component made from uhmwpe and used in combination with all columbus rev f tibial components. the gliding surface is delivered with a screw that corresponds to the insert height. the gliding surface has a post located centrally to interface with the cam on the femoral component. the mechanics of the interface limits rotational motion and provides minimal varus/valgus stability. the implant is used as a component part of a human knee endoprosthesis in combination with columbus revision components during revision of primary knee arthroplasty. both osseous defects and soft tissue dysfunctions can be treated with columbus revision. indicated for severe knee joint conditions that cannot be treated through other therapies: ? degenerative osteoarthritis ? rheumatoid arthritis ? posttraumatic arthritis ? symptomatic knee instability ? knee stiffness ? deformation of the knee joint ? used as revision implants in cases where primary implants have failed

Szingapúr - angol - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - the agilia sp mc syringe pump is intended for use on adults, pediatrics, and neonatal patients for the intermittent or continuous delivery of parenteral fluids (such as solutions, colloids, parenteral nutrition), medications (such as diluted drugs, chemotherapy, anesthesia drugs), blood and blood derivatives, and medications through clinically accepted routes of administration.

Szingapúr - angol - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - the agilia vp mc large volume infusion pump is a peristaltic pump intended for use on adults, pediatrics, and neonatal patients for the intermittent or continuous delivery of parenteral fluids (such as solutions, colloids, parenteral nutrition), medications (such as diluted drugs, chemotherapy, anesthesia drugs), blood and blood derivatives, and medications through clinically accepted routes of administration.

Szingapúr - angol - HSA (Health Sciences Authority)

fresenius kabi (singapore) pte ltd - general hospital - volumat mc agilia is an infusion pump designed for intravenous (iv), administration of drugs, solutions, fluids, parenteral nutrition and transfusion (special set required).

Egyesült Államok - angol - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l), miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - indications:  for use on cats, dogs and horses with bacterial or fungal skin infections that are responsive to chlorhexidine or miconazole. directions for use: shake well before use. bathe 2-3 times per week until symptoms subside or as directed by your veterinarian. wet the animal with cool water from the neck down and apply shampoo first on the skin abnormalities. starting with a quarter-size amount of product, massage into the fur to reach the skin. repeat until the entire body is lightly coated with shampoo. leave shampoo on for 10 minutes before rinsing with cool water. wash hands after use. for a rinse-free solution between baths, use cerasoothe chx+mc antiseptic mousse and/or wipes.

Egyesült Államok - angol - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - chlorhexidine gluconate (unii: mor84mud8e) (chlorhexidine - unii:r4ko0dy52l), miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - indications:  for use on cats, dogs, and horses with bacterial or fungal skin infections that are responsive to chlorhexidine or miconazole. directions for use: shake well before use.brush the fur and then apply on dry hair. apply every 3 days for 2-3 weeks or as directed by your veterinarian. wash hands after use. for localized application: dispense 1 - 2 pumps onto your palm and then apply on the targeted area(s). massage into the skin until fully penetrated. do not rinse, let air dry. once dry, brush the fur again. for whole body application: dispense 1 or 2 pumps onto your palm and then apply on the skin and hair. massage into the skin until fully penetrated. repeat as necessary to cover the whole body, avoiding the eyes and mouth. do not rinse, let air dry. once dry, brush the fur again. dosage: under 11 lbs: 1 pump per 2 lbs 11-88 lbs: 1 pump per 4 lbs over 88 lbs: 1 pump per 6 lbs dosage may be doubled for long-haired dogs. for deeper cleansing, use cerasoothe chx+mc antiseptic shampoo.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - rosuvastatin calcium, quantity: 41.68 mg (equivalent: rosuvastatin, qty 40 mg) - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; pregelatinised starch; crospovidone; microcrystalline cellulose; meglumine; purified water; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red - rosuvastatin mc should be used as an adjunct to diet when the response to diet and exercise is inadequate.,prevention of cardiovascular events,rosuvastatin mc is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). rosuvastatin mc is indicated to:,? reduce the risk of nonfatal myocardial infarction,? reduce the risk of nonfatal stroke,? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia,rosuvastatin mc is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia).,prior to initiating therapy with rosuvastatin mc, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - rosuvastatin calcium, quantity: 20.84 mg (equivalent: rosuvastatin, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; purified water; lactose monohydrate; microcrystalline cellulose; meglumine; pregelatinised starch; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red - rosuvastatin mc should be used as an adjunct to diet when the response to diet and exercise is inadequate.,prevention of cardiovascular events,rosuvastatin mc is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). rosuvastatin mc is indicated to:,? reduce the risk of nonfatal myocardial infarction,? reduce the risk of nonfatal stroke,? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia,rosuvastatin mc is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia).,prior to initiating therapy with rosuvastatin mc, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - rosuvastatin calcium, quantity: 10.42 mg (equivalent: rosuvastatin, qty 10 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; pregelatinised starch; meglumine; purified water; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red - rosuvastatin mc should be used as an adjunct to diet when the response to diet and exercise is inadequate.,prevention of cardiovascular events,rosuvastatin mc is indicated for prevention of major cardiovascular events in men ?50 years old and women ?60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low hdl-c, smoking, or a family history of premature coronary heart disease). rosuvastatin mc is indicated to:,? reduce the risk of nonfatal myocardial infarction,? reduce the risk of nonfatal stroke,? reduce the risk of coronary artery revascularisation procedures.,in patients with hypercholesterolaemia,rosuvastatin mc is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia).,prior to initiating therapy with rosuvastatin mc, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.